the

Not seeing slowdown in tech spends, rather lot of momentum around AI, Copilot: Microsoft India President

Microsoft does not see any slowdown in technology spends in India, the company's India and South Asia President, Puneet Chandok said




the

Facebook, Nvidia ask U.S. Supreme Court to spare them from securities fraud suits

The U.S. Supreme Court is set to consider bids by two tech giants - Meta's Facebook and Nvidia - to fend off federal securities fraud lawsuits in separate cases




the

Royal Enfield unveils Flying Flea C6 and S6, the company’s first-ever electric bikes

In a defining moment for Royal Enfield’s 123-year history, the iconic motorcycle brand introduced its dedicated electric vehicle line, Flying Flea, at the EICMA motorcycle show in Milan




the

Quiz | Easy like Sunday morning: Spot the error

Error, not found! 




the

MapmyIndia forms JV with Hyundai Autoever to offer map-based solutions across Southeast Asia

MapmyIndia will invest $4 million for a 40% stake into the PT Terra Link Technologies while the rest will be owned by Hyundai Autoever




the

The underbelly of Europe’s digital euro

The ECB has presented this central bank digital currency, the digital euro, as a new, better alternative for citizens: free, anonymous, and reliable. But this does not convey its actual purpose




the

The Franz Boas papers / Regna Darnell, general editor

Lincoln : University of Nebraska Press, [2015]-




the

Countering right wing extremism in education [electronic resource] : schooling in the racist badland / Christer Mattsson, Thomas Johansson, and Jesper Andreasson.

Abingdon, Oxon ; New York, NY : Routledge , 2025.




the

Autophagy-focused Casma Therapeutics debuts with $58.5 million from Third Rock

The biotech will first tackle lysosomal storage disorders




the

Chemistry in Pictures: The search is on




the

Chemistry in Pictures: in the mix




the

New battery could serve the grid

Manganese-hydrogen design boasts high capacity, long life, and the promise of low cost




the

Synthorx raises $63 million to make synthetic proteins from an expanded genetic code




the

DuPont, ADM pilot the biobased monomer FDME




the

Let’s hear it from the ACS national meeting

More than 16,000 people showed up to the meeting in New Orleans. Here are a few of their stories




the

Cal Dooley to leave helm of the American Chemistry Council




the

ACS outreach at the USA Science & Engineering Festival and March for Science




the

Crabs gather data with high-tech skin

Flexible, lightweight skin is equipped with sensors, memory, and communications features




the

Evonik keeps the faith in long-term research

German chemical maker seeks to balance technical support and basic R&D that can open new markets




the

Wine sleuths seek answers to the mystery of ‘smoke taint’

As wildfires increase in frequency across the globe, researchers hunt the smoke compounds that can seep into vineyards’ grapes and taint wine




the

Controlling CAR-T: How scientists plan to make the engineered T cell therapy safer, and work for more cancers

CAR T-cell therapy works wonders for some cancer patients. For others, it is a death sentence. To make the revolutionary therapy work for more people, scientists must devise better ways to control it




the

Lilly boosts immunotherapy pipeline with Armo BioSciences acquisition

The drug company will pay $1.6 billion to gain Armo’s IL-10 program




the

Chemical scientists elected to the Royal Society 

Fellows and Foreign Members are recognized for their exceptional contributions to science




the

Sarepta acquires five muscular dystrophy gene therapies from Myonexus




the

Making ACS meetings welcoming portals to the society




the

Changing of the guard at European chemical firms

BASF, Borealis, Covestro, and Solvay bring in new CEOs as they report first-quarter results




the

Your ducky’s microbiome, glow-in-the-dark squirt guns

Toys inspire biology, biology inspires toys




the

At GP-write, scientists take first steps on way to synthetic human genome

At the third meeting of GP-write, researchers decide to create virus-resistant human cells




the

SOCMA head Jennifer Abril wants to take the trade association back to its roots

The nontraditional leader of the specialty chemical manufacturers’ association wants to steer it back to its traditional values




the

Cosmetics that take on the stresses of modern life

As consumers worry about light and air pollution, personal care formulators look for ways to safeguard skin from blue light and other environmental assaults




the

David Liu launches Beam Therapeutics to treat genetic diseases with CRISPR base editing

Joined by CRISPR luminaries Feng Zhang and J. Keith Joung, the Harvard chemist raises up to $87 million in funding




the

Can single-cell genomics lead to a new wave of drug targets? Celsius Therapeutics thinks so

The start-up, based on the work of Broad Institute scientist Aviv Regev, has raised $65 million to develop therapies for cancer and autoimmune disease




the

Tellurium contamination, on the rise, travels to remote areas from industrial sources

As demand for the rare element grows, researchers trace the history of long-range tellurium deposition 




the

Seed partners unveil photosynthesis trait

Benson Hill and Beck’s say corn varieties with the modified gene will yield more per acre




the

Small molecule could help modulate the microbiome 

An inhibitor of starch-digesting enzymes stunts the growth of certain gut bacteria




the

Small molecule could help modulate the microbiome

An inhibitor of starch-digesting enzymes stunts the growth of certain gut bacteria




the

Accent Therapeutics launches to target the epitranscriptomic RNA code in cancer

With $40 million series A funding, the start-up will develop inhibitors of proteins that make chemical modifications to RNA




the

The good times keep rolling in pharmaceutical chemicals

Exhibitors at CPhI North America report another year of record growth and investment




the

Gilead’s Kite adds cell therapy manufacturing capacity




the

Celsius Therapeutics launches to tap single-cell genomics for drug discovery




the

David Liu launches Beam Therapeutics to treat genetic diseases with CRISPR base editing

Joined by CRISPR luminaries Feng Zhang and J. Keith Joung, the Harvard chemist raises up to $87 million in funding




the

Tellurium contamination, on the rise, travels to remote areas from industrial sources

As demand for the rare element grows, researchers trace the history of long-range tellurium deposition




the

What are hair removers, and how do they get rid of unwanted fuzz?

Creams. Wax. Sugar. Lasers. We get to the scientific root of depilation




the

E-cigarettes’ chemistry may explain their popularity among teens

Brands like Juul deliver a form of nicotine that is less harsh to inhale than free-base nicotine




the

Chemists claim they’ve defined the first new class of stereoisomers in 50 years

Akamptisomers result from bond-angle inversion




the

Chemists synthesize and screen massive library of nonnatural proteins

Such screens could yield protein drugs with advantages over natural ones




the

Scientists hit the campaign trail

Provoked by Trump, a wave of candidates pushes for evidence-based governing




the

How chemistry can help meet the UN’s sustainable development goals




the

Mary Sue Coleman on solving the funding crisis in higher education

The chemist and former college president leads the Association of American Universities in challenging times




the

Don’t freak out, Europe, but you might be in the middle of a mustelid uprising